rna seq data analysis pipeline Search Results


arraystudio rna-seq analysis pipeline  (OmicSoft Corporation)
90
OmicSoft Corporation arraystudio rna-seq analysis pipeline
Arraystudio Rna Seq Analysis Pipeline, supplied by OmicSoft Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arraystudio rna-seq analysis pipeline/product/OmicSoft Corporation
Average 90 stars, based on 1 article reviews
arraystudio rna-seq analysis pipeline - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
rna-seq analysis pipeline  (Insphero Inc)
90
Insphero Inc rna-seq analysis pipeline
Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and <t>RNA</t> <t>sequencing</t> <t>(RNA-Seq)</t> were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.
Rna Seq Analysis Pipeline, supplied by Insphero Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna-seq analysis pipeline/product/Insphero Inc
Average 90 stars, based on 1 article reviews
rna-seq analysis pipeline - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
pipeline for rna-seq data analysis (prada)  (SourceForge net)
90
SourceForge net pipeline for rna-seq data analysis (prada)
Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and <t>RNA</t> <t>sequencing</t> <t>(RNA-Seq)</t> were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.
Pipeline For Rna Seq Data Analysis (Prada), supplied by SourceForge net, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pipeline for rna-seq data analysis (prada)/product/SourceForge net
Average 90 stars, based on 1 article reviews
pipeline for rna-seq data analysis (prada) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
corall rna-seq integrated data analysis pipelines  (Lexogen GmbH)
90
Lexogen GmbH corall rna-seq integrated data analysis pipelines
Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and <t>RNA</t> <t>sequencing</t> <t>(RNA-Seq)</t> were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.
Corall Rna Seq Integrated Data Analysis Pipelines, supplied by Lexogen GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/corall rna-seq integrated data analysis pipelines/product/Lexogen GmbH
Average 90 stars, based on 1 article reviews
corall rna-seq integrated data analysis pipelines - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
rna-seq analysis pipelines  (Ruibang Laboratories)
90
Ruibang Laboratories rna-seq analysis pipelines
Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and <t>RNA</t> <t>sequencing</t> <t>(RNA-Seq)</t> were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.
Rna Seq Analysis Pipelines, supplied by Ruibang Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna-seq analysis pipelines/product/Ruibang Laboratories
Average 90 stars, based on 1 article reviews
rna-seq analysis pipelines - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
customized rna-seq data analysis pipeline omicsoft arraysuite version 9  (OmicSoft Corporation)
90
OmicSoft Corporation customized rna-seq data analysis pipeline omicsoft arraysuite version 9
Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and <t>RNA</t> <t>sequencing</t> <t>(RNA-Seq)</t> were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.
Customized Rna Seq Data Analysis Pipeline Omicsoft Arraysuite Version 9, supplied by OmicSoft Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/customized rna-seq data analysis pipeline omicsoft arraysuite version 9/product/OmicSoft Corporation
Average 90 stars, based on 1 article reviews
customized rna-seq data analysis pipeline omicsoft arraysuite version 9 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and RNA sequencing (RNA-Seq) were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.

Journal: Scientific Reports

Article Title: Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model

doi: 10.1038/s41598-024-55438-2

Figure Lengend Snippet: Overview of FibroNest™ platform workflow for fibrosis quantification and MASH induction method. ( A ) FibroNest™ quantitative image analysis workflow and method. ( B ) Scheme for MASH induction in hLiMTs. Disease induction and treatment start at day 0 after the production of the hLiMTs. The three treatment conditions are: LEAN, MASH and MASH in the presence of test compounds. After each medium exchange on days 0, 3, 5 and 7, the compounds and vehicle controls (DMSO or PBS) were applied. FFAs supplementation occurred on each treatment day, while stimulation with LPS took place only once during the 10-day treatment period. Cell culture supernatants and/or microtissues were collected on days 5, 7 and 10. All the end points related to pro-collagen type I/III (pro-coll I/III), Histology/SR, TIMPs/matrix metalloproteinases (MMPs) and RNA sequencing (RNA-Seq) were performed on day 10. All conditions were normalized to 0.2% DMSO or PBS.

Article Snippet: The gene expression data were then analyzed with the InSphero RNA-Seq analysis pipeline.

Techniques: Cell Culture, RNA Sequencing Assay